Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Checkpoint Inhibitor Response Test
EpiSwitch
®
COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EPISWITCH
®
ANALYTICAL PORTAL
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
oxfordbiodynamics
EpiSwitch
®
COVID-19 Severity Test biomarker results published
Press release
by oxfordbiodynamics
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
bioRxiv, March 2021
by oxfordbiodynamics
Annual Report & Accounts 2020
Results
by oxfordbiodynamics
CEO presentation on OBD’s expanded strategic focus
Video Link
by oxfordbiodynamics
Oxford BioDynamics to expand strategic focus
Press Release
by oxfordbiodynamics
Appointment of Chairman for Oxford Biodynamics Plc
Press Release
by oxfordbiodynamics
Strategic partnership with Boca Biolistics
Press Release
by oxfordbiodynamics
Disease severity program for COVID-19 advances
Press Release
by oxfordbiodynamics
Interim results for six months ended 31 March 2020
PDF
Press Release
by oxfordbiodynamics
Industry expert Dr Peter Pack, appointed as Non-Executive Chairman, succeeding Stephen Diggle
Press Release
by oxfordbiodynamics
1
2
3
4
…
11
Privacy Preference Center
Privacy Preferences
